conv.

← The whole story
Health
Epigenetic editing shows promise against chronic hepatitis B in early trials

Study published on epigenetic editing for hepatitis B

nChroma Bio and institutes in Milan published findings in Nature Biomedical Engineering showing that epigenetic editing—using chemical tags rather than DNA cuts—can shut down hepatitis B viral gene activity. Preclinical tests in human liver cells and mice showed promising efficacy, with only minimal and temporary side effects in primate testing.

Study published on epigenetic editing for hepatitis B
nature.com

“The efficacy of a single injection was "quite impressive". This "is really where we need to go to end up being able to address this pandemic of HBV around the world".”

John Tavis

nChroma Bio Biotechnology firm developing CRMA-1001Angelo Lombardo Molecular biologist, San Raffaele Telethon Institute; nChroma Bio co-founderJohn Tavis Molecular virologist, Saint Louis UniversityFabien Zoulim Virologist and clinical hepatologist, University of Lyon

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 1 piece in one hour at Sep 20, 7 PM; 3 pieces over 3 days (1 article · 2 posts) Sep 20, 7 PM — 1 piece · 1 article — Newswires 1Sep 20, 8 PM — quietSep 20, 9 PM — quietSep 20, 10 PM — quietSep 20, 11 PM — quietSep 21, 12 AM — quietSep 21, 1 AM — quietSep 21, 2 AM — quietSep 21, 3 AM — quietSep 21, 4 AM — quietSep 21, 5 AM — quietSep 21, 6 AM — quietSep 21, 7 AM — quietSep 21, 8 AM — quietSep 21, 9 AM — quietSep 21, 10 AM — quietSep 21, 11 AM — quietSep 21, 12 PM — quietSep 21, 1 PM — quietSep 21, 2 PM — quietSep 21, 3 PM — quietSep 21, 4 PM — quietSep 21, 5 PM — 1 piece · 1 post — Hacker News 1Sep 21, 6 PM — quietSep 21, 7 PM — quietSep 21, 8 PM — quietSep 21, 9 PM — quietSep 21, 10 PM — quietSep 21, 11 PM — quietSep 22, 12 AM — quietSep 22, 1 AM — 1 piece · 1 post — Mastodon 1Sep 22, 2 AM — quietSep 22, 3 AM — quietSep 22, 4 AM — quietSep 22, 5 AM — quietSep 22, 6 AM — quietSep 22, 7 AM — quietSep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quietToday, 1 AM — quietToday, 2 AM — quietToday, 3 AM — quietToday, 4 AM — quiet 1
Sep 21Sep 22yesterdaynow · 5:05 AM ET

What was reported 1 claim about this development

  1. first by Nature News, 3d ago

All 1 developments of Epigenetic editing shows promise against chronic hepatitis… →

NewswiresHacker NewsMastodon